COVID-19 Impact on Global Mycosis Fungoides Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C7D264D78371EN
QYResearch

Abstracts

This report focuses on the global Mycosis Fungoides Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mycosis Fungoides Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astellas Pharma
• Bayer AG
• Dover Medical and Scientific Equipment, Ltd.
• Elorac, Inc.
• Kyowa Kirin, Inc.
• Macopharma
• Soligenix, Inc.
• Varian Medical Systems
• Yaupon Therapeutics

Market segment by Type, the product can be split into

• Topical Steroids
• Mechlorethamine Gel
• HDAC Inhibitors
• Monoclonal Antibodies
• Localized Radiation Therapy
• Extracorporeal Photopheresis
• Others

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Mycosis Fungoides Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Mycosis Fungoides Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Mycosis Fungoides Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mycosis Fungoides Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Mycosis Fungoides Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Topical Steroids
  1.4.3 Mechlorethamine Gel
  1.4.4 HDAC Inhibitors
  1.4.5 Monoclonal Antibodies
  1.4.6 Localized Radiation Therapy
  1.4.7 Extracorporeal Photopheresis
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Mycosis Fungoides Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Mycosis Fungoides Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Mycosis Fungoides Treatment Industry
    1.6.1.1 Mycosis Fungoides Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Mycosis Fungoides Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Mycosis Fungoides Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Mycosis Fungoides Treatment Market Perspective (2015-2026)
2.2 Mycosis Fungoides Treatment Growth Trends by Regions
  2.2.1 Mycosis Fungoides Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Mycosis Fungoides Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Mycosis Fungoides Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Mycosis Fungoides Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Mycosis Fungoides Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Mycosis Fungoides Treatment Players by Market Size
  3.1.1 Global Top Mycosis Fungoides Treatment Players by Revenue (2015-2020)
  3.1.2 Global Mycosis Fungoides Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mycosis Fungoides Treatment Market Concentration Ratio
  3.2.1 Global Mycosis Fungoides Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Treatment Revenue in 2019
3.3 Mycosis Fungoides Treatment Key Players Head office and Area Served
3.4 Key Players Mycosis Fungoides Treatment Product Solution and Service
3.5 Date of Enter into Mycosis Fungoides Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Mycosis Fungoides Treatment Historic Market Size by Type (2015-2020)
4.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Type (2021-2026)

5 MYCOSIS FUNGOIDES TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Mycosis Fungoides Treatment Market Size by Application (2015-2020)
5.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Mycosis Fungoides Treatment Market Size (2015-2020)
6.2 Mycosis Fungoides Treatment Key Players in North America (2019-2020)
6.3 North America Mycosis Fungoides Treatment Market Size by Type (2015-2020)
6.4 North America Mycosis Fungoides Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Mycosis Fungoides Treatment Market Size (2015-2020)
7.2 Mycosis Fungoides Treatment Key Players in Europe (2019-2020)
7.3 Europe Mycosis Fungoides Treatment Market Size by Type (2015-2020)
7.4 Europe Mycosis Fungoides Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Mycosis Fungoides Treatment Market Size (2015-2020)
8.2 Mycosis Fungoides Treatment Key Players in China (2019-2020)
8.3 China Mycosis Fungoides Treatment Market Size by Type (2015-2020)
8.4 China Mycosis Fungoides Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Mycosis Fungoides Treatment Market Size (2015-2020)
9.2 Mycosis Fungoides Treatment Key Players in Japan (2019-2020)
9.3 Japan Mycosis Fungoides Treatment Market Size by Type (2015-2020)
9.4 Japan Mycosis Fungoides Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Mycosis Fungoides Treatment Market Size (2015-2020)
10.2 Mycosis Fungoides Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mycosis Fungoides Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Mycosis Fungoides Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Mycosis Fungoides Treatment Market Size (2015-2020)
11.2 Mycosis Fungoides Treatment Key Players in India (2019-2020)
11.3 India Mycosis Fungoides Treatment Market Size by Type (2015-2020)
11.4 India Mycosis Fungoides Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Mycosis Fungoides Treatment Market Size (2015-2020)
12.2 Mycosis Fungoides Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Mycosis Fungoides Treatment Market Size by Type (2015-2020)
12.4 Central & South America Mycosis Fungoides Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas Pharma
  13.1.1 Astellas Pharma Company Details
  13.1.2 Astellas Pharma Business Overview and Its Total Revenue
  13.1.3 Astellas Pharma Mycosis Fungoides Treatment Introduction
  13.1.4 Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2015-2020))
  13.1.5 Astellas Pharma Recent Development
13.2 Bayer AG
  13.2.1 Bayer AG Company Details
  13.2.2 Bayer AG Business Overview and Its Total Revenue
  13.2.3 Bayer AG Mycosis Fungoides Treatment Introduction
  13.2.4 Bayer AG Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.2.5 Bayer AG Recent Development
13.3 Dover Medical and Scientific Equipment, Ltd.
  13.3.1 Dover Medical and Scientific Equipment, Ltd. Company Details
  13.3.2 Dover Medical and Scientific Equipment, Ltd. Business Overview and Its Total Revenue
  13.3.3 Dover Medical and Scientific Equipment, Ltd. Mycosis Fungoides Treatment Introduction
  13.3.4 Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.3.5 Dover Medical and Scientific Equipment, Ltd. Recent Development
13.4 Elorac, Inc.
  13.4.1 Elorac, Inc. Company Details
  13.4.2 Elorac, Inc. Business Overview and Its Total Revenue
  13.4.3 Elorac, Inc. Mycosis Fungoides Treatment Introduction
  13.4.4 Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.4.5 Elorac, Inc. Recent Development
13.5 Kyowa Kirin, Inc.
  13.5.1 Kyowa Kirin, Inc. Company Details
  13.5.2 Kyowa Kirin, Inc. Business Overview and Its Total Revenue
  13.5.3 Kyowa Kirin, Inc. Mycosis Fungoides Treatment Introduction
  13.5.4 Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.5.5 Kyowa Kirin, Inc. Recent Development
13.6 Macopharma
  13.6.1 Macopharma Company Details
  13.6.2 Macopharma Business Overview and Its Total Revenue
  13.6.3 Macopharma Mycosis Fungoides Treatment Introduction
  13.6.4 Macopharma Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.6.5 Macopharma Recent Development
13.7 Soligenix, Inc.
  13.7.1 Soligenix, Inc. Company Details
  13.7.2 Soligenix, Inc. Business Overview and Its Total Revenue
  13.7.3 Soligenix, Inc. Mycosis Fungoides Treatment Introduction
  13.7.4 Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.7.5 Soligenix, Inc. Recent Development
13.8 Varian Medical Systems
  13.8.1 Varian Medical Systems Company Details
  13.8.2 Varian Medical Systems Business Overview and Its Total Revenue
  13.8.3 Varian Medical Systems Mycosis Fungoides Treatment Introduction
  13.8.4 Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.8.5 Varian Medical Systems Recent Development
13.9 Yaupon Therapeutics
  13.9.1 Yaupon Therapeutics Company Details
  13.9.2 Yaupon Therapeutics Business Overview and Its Total Revenue
  13.9.3 Yaupon Therapeutics Mycosis Fungoides Treatment Introduction
  13.9.4 Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2015-2020)
  13.9.5 Yaupon Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Mycosis Fungoides Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Mycosis Fungoides Treatment Revenue
Table 3. Ranking of Global Top Mycosis Fungoides Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mycosis Fungoides Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Topical Steroids
Table 6. Key Players of Mechlorethamine Gel
Table 7. Key Players of HDAC Inhibitors
Table 8. Key Players of Monoclonal Antibodies
Table 9. Key Players of Localized Radiation Therapy
Table 10. Key Players of Extracorporeal Photopheresis
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Mycosis Fungoides Treatment Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Mycosis Fungoides Treatment Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Mycosis Fungoides Treatment Players to Combat Covid-19 Impact
Table 17. Global Mycosis Fungoides Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Mycosis Fungoides Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Mycosis Fungoides Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Mycosis Fungoides Treatment Market Share by Regions (2015-2020)
Table 21. Global Mycosis Fungoides Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Mycosis Fungoides Treatment Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Mycosis Fungoides Treatment Market Growth Strategy
Table 27. Main Points Interviewed from Key Mycosis Fungoides Treatment Players
Table 28. Global Mycosis Fungoides Treatment Revenue by Players (2015-2020) (Million US$)
Table 29. Global Mycosis Fungoides Treatment Market Share by Players (2015-2020)
Table 30. Global Top Mycosis Fungoides Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Treatment as of 2019)
Table 31. Global Mycosis Fungoides Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Mycosis Fungoides Treatment Product Solution and Service
Table 34. Date of Enter into Mycosis Fungoides Treatment Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. Global Mycosis Fungoides Treatment Market Size Share by Type (2015-2020)
Table 38. Global Mycosis Fungoides Treatment Revenue Market Share by Type (2021-2026)
Table 39. Global Mycosis Fungoides Treatment Market Size Share by Application (2015-2020)
Table 40. Global Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. Global Mycosis Fungoides Treatment Market Size Share by Application (2021-2026)
Table 42. North America Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 44. North America Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. North America Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 46. North America Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. North America Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 48. Europe Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 50. Europe Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 52. Europe Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 54. China Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 55. China Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 56. China Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. China Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 58. China Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. China Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 60. Japan Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 62. Japan Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 64. Japan Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 68. Southeast Asia Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 70. Southeast Asia Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 72. India Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 73. India Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 74. India Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. India Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 76. India Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. India Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Mycosis Fungoides Treatment Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Mycosis Fungoides Treatment Market Share (2019-2020)
Table 80. Central & South America Mycosis Fungoides Treatment Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Mycosis Fungoides Treatment Market Share by Type (2015-2020)
Table 82. Central & South America Mycosis Fungoides Treatment Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Mycosis Fungoides Treatment Market Share by Application (2015-2020)
Table 84. Astellas Pharma Company Details
Table 85. Astellas Pharma Business Overview
Table 86. Astellas Pharma Product
Table 87. Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 88. Astellas Pharma Recent Development
Table 89. Bayer AG Company Details
Table 90. Bayer AG Business Overview
Table 91. Bayer AG Product
Table 92. Bayer AG Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 93. Bayer AG Recent Development
Table 94. Dover Medical and Scientific Equipment, Ltd. Company Details
Table 95. Dover Medical and Scientific Equipment, Ltd. Business Overview
Table 96. Dover Medical and Scientific Equipment, Ltd. Product
Table 97. Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 98. Dover Medical and Scientific Equipment, Ltd. Recent Development
Table 99. Elorac, Inc. Company Details
Table 100. Elorac, Inc. Business Overview
Table 101. Elorac, Inc. Product
Table 102. Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 103. Elorac, Inc. Recent Development
Table 104. Kyowa Kirin, Inc. Company Details
Table 105. Kyowa Kirin, Inc. Business Overview
Table 106. Kyowa Kirin, Inc. Product
Table 107. Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 108. Kyowa Kirin, Inc. Recent Development
Table 109. Macopharma Company Details
Table 110. Macopharma Business Overview
Table 111. Macopharma Product
Table 112. Macopharma Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 113. Macopharma Recent Development
Table 114. Soligenix, Inc. Company Details
Table 115. Soligenix, Inc. Business Overview
Table 116. Soligenix, Inc. Product
Table 117. Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 118. Soligenix, Inc. Recent Development
Table 119. Varian Medical Systems Business Overview
Table 120. Varian Medical Systems Product
Table 121. Varian Medical Systems Company Details
Table 122. Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 123. Varian Medical Systems Recent Development
Table 124. Yaupon Therapeutics Company Details
Table 125. Yaupon Therapeutics Business Overview
Table 126. Yaupon Therapeutics Product
Table 127. Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2015-2020) (Million US$)
Table 128. Yaupon Therapeutics Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Mycosis Fungoides Treatment Market Share by Type: 2020 VS 2026
Figure 2. Topical Steroids Features
Figure 3. Mechlorethamine Gel Features
Figure 4. HDAC Inhibitors Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Localized Radiation Therapy Features
Figure 7. Extracorporeal Photopheresis Features
Figure 8. Others Features
Figure 9. Global Mycosis Fungoides Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Mycosis Fungoides Treatment Report Years Considered
Figure 14. Global Mycosis Fungoides Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Mycosis Fungoides Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Mycosis Fungoides Treatment Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Mycosis Fungoides Treatment Market Share by Players in 2019
Figure 19. Global Top Mycosis Fungoides Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycosis Fungoides Treatment as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Mycosis Fungoides Treatment Revenue in 2019
Figure 21. North America Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Mycosis Fungoides Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Astellas Pharma Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 30. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Bayer AG Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 32. Dover Medical and Scientific Equipment, Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Dover Medical and Scientific Equipment, Ltd. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 34. Elorac, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Elorac, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 36. Kyowa Kirin, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Kyowa Kirin, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 38. Macopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Macopharma Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 40. Soligenix, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Soligenix, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 42. Varian Medical Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Varian Medical Systems Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 44. Yaupon Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Yaupon Therapeutics Revenue Growth Rate in Mycosis Fungoides Treatment Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed